DE59407041D1 - Ursodeoxycholsäure enthaltendes Arzneimittel in flüssiger Darreichungsform - Google Patents

Ursodeoxycholsäure enthaltendes Arzneimittel in flüssiger Darreichungsform

Info

Publication number
DE59407041D1
DE59407041D1 DE59407041T DE59407041T DE59407041D1 DE 59407041 D1 DE59407041 D1 DE 59407041D1 DE 59407041 T DE59407041 T DE 59407041T DE 59407041 T DE59407041 T DE 59407041T DE 59407041 D1 DE59407041 D1 DE 59407041D1
Authority
DE
Germany
Prior art keywords
active compound
ursodeoxycholic acid
dosage form
liquid dosage
children
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE59407041T
Other languages
English (en)
Inventor
Josef Olaf Widauer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medichemie AG
Original Assignee
Medichemie AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medichemie AG filed Critical Medichemie AG
Application granted granted Critical
Publication of DE59407041D1 publication Critical patent/DE59407041D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
DE59407041T 1993-08-30 1994-08-16 Ursodeoxycholsäure enthaltendes Arzneimittel in flüssiger Darreichungsform Expired - Lifetime DE59407041D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH256793 1993-08-30

Publications (1)

Publication Number Publication Date
DE59407041D1 true DE59407041D1 (de) 1998-11-12

Family

ID=4236712

Family Applications (1)

Application Number Title Priority Date Filing Date
DE59407041T Expired - Lifetime DE59407041D1 (de) 1993-08-30 1994-08-16 Ursodeoxycholsäure enthaltendes Arzneimittel in flüssiger Darreichungsform

Country Status (8)

Country Link
US (1) US5534505A (de)
EP (1) EP0640344B1 (de)
JP (1) JP3631782B2 (de)
AT (1) ATE171874T1 (de)
CA (1) CA2130787C (de)
DE (1) DE59407041D1 (de)
DK (1) DK0640344T3 (de)
ES (1) ES2121599T3 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1113785B1 (de) * 1998-07-24 2005-04-13 Seo Hong Yoo Klare wässrige lösungen enthaltend gallensäuren
US20050158408A1 (en) * 1998-07-24 2005-07-21 Yoo Seo H. Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
US7303768B2 (en) * 1998-07-24 2007-12-04 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
US7772220B2 (en) * 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
EP1255566A2 (de) * 2000-02-04 2002-11-13 Seo Hong Yoo Herstellung von gallensäuren enthaltenden wässrigen klaren lösungen
EP1147779B1 (de) * 2000-04-20 2006-05-31 BIOPROGRESS S.p.A. Verfahren zur Herstellung ursodeoxycholsäure enthaltender pharmazeutischer Zusammensetzungen in flüssiger Form
US7145125B2 (en) 2003-06-23 2006-12-05 Advanced Optical Technologies, Llc Integrating chamber cone light using LED sources
WO2005042026A1 (ja) * 2003-10-31 2005-05-12 Wakamoto Pharmaceutical Co., Ltd. 可逆性熱ゲル化水性組成物
ATE464883T1 (de) * 2004-07-22 2010-05-15 Bend Res Inc Geschmacksabdeckende formulierung mit einer retardierten wirkstoffformulierung und/oder schnell löslichem cyclodextrin
ES2339790T3 (es) * 2004-08-30 2010-05-25 Seo Hong Yoo Efecto neuroprotector de udca solubilizado en modelo isquemico focal.
ATE506955T1 (de) * 2004-10-15 2011-05-15 Seo Hong Yoo Zusammensetzungen zur verringerung der toxizität von cisplatin, carboplatin und oxaliplatin
CA2585471A1 (en) * 2004-11-01 2006-05-11 Seo Hong Yoo Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis
WO2008025560A1 (en) * 2006-09-01 2008-03-06 Pari Pharma Gmbh Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy
JP2010503667A (ja) * 2006-09-15 2010-02-04 ホン ユー，ソ 大腸疾患用胆汁製剤
GB0817969D0 (en) * 2008-10-01 2008-11-05 Axcess Ltd Pharmaceutical composition
EP2208497A1 (de) 2009-01-15 2010-07-21 Charité-Universitätsmedizin Berlin (Charité) Verwendung von Ursodesoxycholsäure (UDCA) zum Verbessern des allgemeinen Gesundheitszustands eines Tumorpatienten
BR112014010223B8 (pt) * 2011-10-28 2021-02-23 Lumena Pharmaceuticals Llc uso de uma composição compreendendo inibidores de reciclagem de ácido de bílis e forma de dosagem pediátrica
US10016357B2 (en) * 2012-03-22 2018-07-10 The Beauty Factory, Llc Personal lubricants
MX2014016022A (es) 2013-06-21 2015-08-13 Dode S A Contenedor plegable.
WO2016019066A1 (en) * 2014-07-29 2016-02-04 University Of Tennessee Research Foundation Composition and method for treating liver disease
WO2021099973A1 (en) 2019-11-22 2021-05-27 Shilpa Medicare Limited Injectable compositions of ursodeoxycholic acid
CN115068418B (zh) * 2022-07-20 2022-10-28 奥信阳光(北京)药业科技有限公司 一种熊去氧胆酸口服溶液及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639597A (en) * 1968-02-02 1972-02-01 Merck & Co Inc Pharmaceutical compositions containing cholanic acid conjugates
DE2757641C2 (de) * 1977-12-23 1980-03-06 Rowa Ltd., Bantry, Cork (Irland) Verwendung von cis-(33Ä-Trimethylcyclohexanol zur Behandlung von Galleleiden
JPS5522616A (en) * 1978-08-04 1980-02-18 Tokyo Tanabe Co Ltd Bile acid inclusion compound and injection containing the same
US4264583A (en) * 1979-07-25 1981-04-28 The Procter & Gamble Company Gallstone dissolution compositions and method
JPS62153220A (ja) * 1985-12-27 1987-07-08 Tokyo Tanabe Co Ltd 胆汁酸内用水剤
IT1245889B (it) * 1991-04-12 1994-10-25 Alfa Wassermann Spa Formulazioni farmaceutiche per uso orale gastroresistenti contenenti sali di acidi biliari.

Also Published As

Publication number Publication date
CA2130787C (en) 2006-12-05
EP0640344B1 (de) 1998-10-07
JPH0782150A (ja) 1995-03-28
JP3631782B2 (ja) 2005-03-23
EP0640344A1 (de) 1995-03-01
CA2130787A1 (en) 1995-03-01
DK0640344T3 (da) 1999-07-05
ATE171874T1 (de) 1998-10-15
US5534505A (en) 1996-07-09
ES2121599T3 (es) 1998-12-01

Similar Documents

Publication Publication Date Title
ATE171874T1 (de) Ursodeoxycholsäure enthaltendes arzneimittel in flüssiger darreichungsform
US4661354A (en) Topical treatment of herpes simplex with a zinc sulfate-camphor water solution
DE2840442C2 (de) Verwendung des Diketopiperazins L-Leu-L-Trp als Geschmacksstoff für Getränke mit bitterer Geschmacksrichtung
KR880004807A (ko) 수산화알루미늄을 함유하는 이부프로펜 조성물
CY2503B1 (en) Novel formulations for the transdermal administration of fluoxetine acetate and fluoxetine maleate.
CH693982A5 (de) Cefuroximaxetil enthaltende Zusammensetzung.
AT4423U1 (de) Zusammensetzung umfassend amoxycillin und clavulansäure
CN110193008A (zh) 一种左乙拉西坦口服溶液及其制备方法
HU9400430D0 (en) New pyrazine derivatives, their preparation and pharmaceutical compositions containing them
DE2211019B2 (de) Geschmacksverbessernde Formulierungen oraler Penicilline
JPS62153220A (ja) 胆汁酸内用水剤
US20220378803A1 (en) Injectable compositions of ursodeoxycholic acid
RU2002135599A (ru) Способ повышения антиокислительного потенциала селенсодержащих водных растворов
ES2436213T3 (es) Una formulación en suspensión estable de clozapina
US5955456A (en) Injectable pharmaceutical composition comprising ursodesoxycholic acid or tauroursodesoxycholic acid, a strong base and tromethamol
ATE178208T1 (de) Capsaicin enthaltendes arzneimittel zur behandlung chronischer rhinopathie
JPH0376291B2 (de)
JPH0698729A (ja) 朝鮮人参エキス含有飲料とその製造方法
JPH0473411B2 (de)
CN106344500A (zh) 一种增强免疫的口服液体制剂
DE2531201C2 (de) Aminosäure-Infusionslösungen für die Verwendung bei Frühgeburten bis Kleinkindern
JPH11139970A (ja) 経口液剤
CN104771365A (zh) 一种右旋布洛芬干混悬剂及制备方法
AU621677B2 (en) Stable aqueous solutions of primycin, pharmaceutical and cosmetic compositions containing these solutions and process for preparing same
KR900701263A (ko) 이보파민의 수용성 산 부가 염을 포함하는 안과용 약학 조성물

Legal Events

Date Code Title Description
8364 No opposition during term of opposition